Peptide Structure: Primary, Secondary, Tertiary & Cyclic Conformations

Peptides exhibit structural architecture that mirrors protein hierarchy but operates under unique physical constraints [1]:

• Primary Structure: The covalent linear sequence of amino acids from the N-terminus to the C-terminus, defined by peptide bonds and disulfide crosslinks.
• Secondary Structure: Local spatial arrangements of the polypeptide backbone stabilized by hydrogen bonds (alpha-helices, 3₁₀-helices, beta-strands, and reverse turns).
• Tertiary Structure: The overall three-dimensional folding of the peptide chain, mediated by hydrophobic packing, salt bridges, and disulfide bridges.

Unlike globular proteins whose hydrophobic cores drive them into a single, well-defined free-energy minimum, short linear peptides (fewer than 20–30 residues) typically lack sufficient tertiary packing interactions to maintain a rigid fold in water [2].

Instead, linear peptides exist in aqueous solution as dynamic conformational ensembles (often termed intrinsically disordered states), rapidly interconverting between transient conformations. Many disordered segments fold upon binding to their biological targets (coupled folding and binding), adopting the bioactive conformation only in the bound state [2].

When peptides dock into receptors, they frequently adopt canonical secondary structural motifs [1]:

• Alpha-Helix: A right-handed spiral where every backbone N-H group forms a hydrogen bond with the C=O group of the residue four positions earlier (i → i+4). Residues project outward radially every 3.6 residues (5.4 Å pitch), creating amphipathic faces that interact simultaneously with receptors and membranes (as seen in GLP-1, GIP, and PTH).
• Beta-Turns: Four-residue loops (i → i+3 hydrogen bond) that reverse the polypeptide backbone trajectory by 180 degrees, presenting pharmacophoric side chains into receptor clefts.
• Disulfide-Stabilized Loops: Intramolecular cystine bridges (as seen in oxytocin and vasopressin) that constrain small peptide rings into rigid recognition hairpins [3].

To reduce the flexibility that permits rapid protease degradation, medicinal chemists utilize macrocyclization; macrocycles are of particular interest for difficult targets such as protein-protein interactions [4]. Macrocyclic peptides can be circularized via:

• Head-to-tail amide cyclization: Connecting the N-terminal amine to the C-terminal carboxylate (as in epitalon analogues or cyclosporine).
• Side-chain-to-tail / side-chain-to-head linkages: Linking lysine amines to C-terminal acids or aspartate/glutamate carboxyls to N-terminal amines.
• Disulfide or Thioether bridges: Establishing covalent crosslinks across internal cysteine residues (as in octreotide and lanreotide).

Cyclization removes free termini targeted by exopeptidases and can pre-organize binding residues, which may improve stability and target binding.

A breakthrough technology for targeting intracellular protein-protein interactions (PPIs) is hydrocarbon peptide stapling [5].

Chemists incorporate unnatural alpha,alpha-disubstituted amino acids bearing terminal olefin (alkene) chains at positions i and i+4 or i and i+7. Ruthenium-catalyzed ring-closing metathesis (RCM) links these hydrocarbon arms into an all-hydrocarbon crosslink ('staple'). When design principles are applied successfully, this staple can confer alpha-helical structure, protease resistance, and cellular penetrance [5].